Healthcare Analytics Startup OM1 Raises $15M | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Healthcare Analytics Startup OM1 Raises $15M

April 14, 2017
by David Raths
| Reprints
Funding to support build-out of company’s outcomes measurement and machine learning technology

OM1, a Cambridge, Mass.-based startup focused on providing outcomes measurement and predictive analytics for value-based and personalized healthcare, has raised a series A financing round of $15 million.

OM1 says its system gathers, synthesizes, enriches and leverages clinical data to provide measurements and artificial intelligence-driven insights and predictions that can improve clinical, financial, and operational management. The company said its analytics can help healthcare organizations better optimize care for both individuals and populations, can inform smart supply chain decisions, and can provide a clearer link between outcomes and value — enabling risk-bearing entities to succeed under value-based care.

The company is led by CEO Richard Gliklich, M.D., who previously founded a company called Outcome, which he led from inception through its acquisition by Quintiles. His work has focused on registries, outcomes and analytics. He is senior editor of “Registries for Evaluating Patient Outcomes: A User's Guide” published by the U.S. Agency for Healthcare Research and Quality. 

With the funding, led by General Catalyst and with participation from Glikvest, 7wire Ventures and Wanxiang Healthcare Investments, OM1 will continue the build-out of its outcomes measurement and machine learning technology.

“To improve healthcare across the board we need to fundamentally understand real-world results and become much better at both predicting at-risk patients and assessing potential treatment options for them,” Gliklich said in a prepared statement. “The system that we're building at OM1 will give providers unprecedented insight on the relationship between care and outcomes, helping them to avoid high-cost events and ultimately provide the best care possible. At the same time, we're focused on helping researchers and payers to more quickly and accurately generate real-world evidence and better understand the connection between outcomes and value.”

The funding announcement follows the addition of Gary Gottlieb, M.D., M.B.A., the CEO of Partners in Health and former President and CEO of Partners HealthCare, to the OM1 board of directors last year. In addition to his role at Partners in Health, Dr. Gottlieb is a professor of psychiatry at Harvard Medical School and serves as the chairman of the board of directors of the Federal Reserve Bank of Boston.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.